ASHG News

21st Century Human Genetics: Challenges and Opportunities

Nascent Transcript Writer: Sumantra Chatterjee, PhD Large scale exome and whole genome sequencing have led to cataloging vast arrays of disease-associated genes and variants for various multifactorial disorders, yet the underlying biology for most of these has been difficult to unravel, leading to diagnostic uncertainty. This has been partly due to our incomplete knowledge of... Read More

Trainee Paper Spotlight: Yuetiva (Deming) Robles

Trainee Author: Yuetiva (Deming) Robles, PhD Postdoctoral Trainee University of Wisconsin-Madison (Photo courtesy Robles) Deming Y, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk. 2019 Aug 14;505(11) In this study, Deming et al. identify the MS4A gene cluster as a regulator of soluble TREM2 (sTREM2), a... Read More

Researchers Quantify Cas9-Caused Off-Target Mutagenesis in Mice

Published: Friday, October 18, 2019, 5:35 p.m. U.S. Eastern Time Media Contact: Nalini Padmanabhan, 301.634.7346, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – Scientists are finding new ways to improve the use of the CRISPR enzyme Cas9 and reduce the chances of off-target mutations in laboratory mice, according to new results from... Read More

Researchers Quantify Limitations of Health Reports from Direct-to-Consumer Genetic Tests

Published: Thursday, October 17, 2019, 5:00 p.m. U.S. Central Time Media Contact: Ann Klinck, 301.634.7342, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – Health reports from direct-to-consumer (DTC) genetic tests that use a limited variant screening approach often yield clinical false-negative results, which pose the risk of informing health care decisions based... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy